BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 29340035)

  • 1.
    Li W; Zhang D; Du F; Xing X; Wu Y; Xiao D; Liang M; Fan Z; Zhao P; Liu T; Li G
    Oncotarget; 2017 Dec; 8(67):111041-111052. PubMed ID: 29340035
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Association of ABCB1 and ABCG2 single nucleotide polymorphisms with clinical findings and response to chemotherapy treatments in Kurdish patients with breast cancer.
    Ghafouri H; Ghaderi B; Amini S; Nikkhoo B; Abdi M; Hoseini A
    Tumour Biol; 2016 Jun; 37(6):7901-6. PubMed ID: 26700668
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Concurrent effects of ABCB1 C3435T, ABCG2 C421A, and XRCC1 Arg194Trp genetic polymorphisms with risk of cancer, clinical output, and response to treatment with imatinib mesylate in patients with chronic myeloid leukemia.
    Salimizand H; Amini S; Abdi M; Ghaderi B; Azadi NA
    Tumour Biol; 2016 Jan; 37(1):791-8. PubMed ID: 26250462
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of ABCB1 polymorphism on the clinical outcome of osteosarcoma patients after receiving chemotherapy.
    Xiaohui S; Aiguo L; Xiaolin G; Ying L; Hongxing Z; Yilei Z
    Pak J Med Sci; 2014 Jul; 30(4):886-90. PubMed ID: 25097538
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Association between ABCB1, ABCG2 carrier protein and COX-2 enzyme gene polymorphisms and breast cancer risk in a Turkish population.
    Zeliha KP; Dilek O; Ezgi O; Halil K; Cihan U; Gul O
    Saudi Pharm J; 2020 Feb; 28(2):215-219. PubMed ID: 32042261
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Roles of ABCB1 gene polymorphisms and haplotype in susceptibility to breast carcinoma risk and clinical outcomes.
    Wu H; Kang H; Liu Y; Tong W; Liu D; Yang X; Lian M; Yao W; Zhao H; Huang D; Sha X; Wang E; Wei M
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1449-62. PubMed ID: 22526155
    [TBL] [Abstract][Full Text] [Related]  

  • 7. ABCB1 C3435T gene polymorphism as a potential biomarker of clinical outcomes in HER2-positive breast cancer patients.
    Madrid-Paredes A; Cañadas-Garre M; Sánchez-Pozo A; Segura-Pérez AM; Chamorro-Santos C; Vergara-Alcaide E; Castillo-Portellano L; Calleja-Hernández MÁ
    Pharmacol Res; 2016 Jun; 108():111-118. PubMed ID: 27137881
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Association of genotypes and haplotypes of multi-drug transporter genes ABCB1 and ABCG2 with clinical response to imatinib mesylate in chronic myeloid leukemia patients.
    Au A; Aziz Baba A; Goh AS; Wahid Fadilah SA; Teh A; Rosline H; Ankathil R
    Biomed Pharmacother; 2014 Apr; 68(3):343-9. PubMed ID: 24581936
    [TBL] [Abstract][Full Text] [Related]  

  • 9. ABCB1 polymorphism as prognostic factor in breast cancer patients treated with docetaxel and doxorubicin neoadjuvant chemotherapy.
    Kim HJ; Im SA; Keam B; Ham HS; Lee KH; Kim TY; Kim YJ; Oh DY; Kim JH; Han W; Jang IJ; Kim TY; Park IA; Noh DY
    Cancer Sci; 2015 Jan; 106(1):86-93. PubMed ID: 25410489
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive value of ABCB1 polymorphisms G2677T/A, C3435T, and their haplotype in small cell lung cancer patients treated with chemotherapy.
    Knez L; Košnik M; Ovčariček T; Sadikov A; Sodja E; Kern I; Cufer T
    J Cancer Res Clin Oncol; 2012 Sep; 138(9):1551-60. PubMed ID: 22543673
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Epigenetic modulation of the drug resistance genes MGMT, ABCB1 and ABCG2 in glioblastoma multiforme.
    Oberstadt MC; Bien-Möller S; Weitmann K; Herzog S; Hentschel K; Rimmbach C; Vogelgesang S; Balz E; Fink M; Michael H; Zeden JP; Bruckmüller H; Werk AN; Cascorbi I; Hoffmann W; Rosskopf D; Schroeder HW; Kroemer HK
    BMC Cancer; 2013 Dec; 13():617. PubMed ID: 24380367
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Influence of CYP3A5*3 and ABCB1 C3435T on clinical outcomes and trough plasma concentrations of imatinib in Nigerians with chronic myeloid leukaemia.
    Adeagbo BA; Bolaji OO; Olugbade TA; Durosinmi MA; Bolarinwa RA; Masimirembwa C
    J Clin Pharm Ther; 2016 Oct; 41(5):546-51. PubMed ID: 27426203
    [TBL] [Abstract][Full Text] [Related]  

  • 13. ABCB1 and ABCG2 Together Limit the Distribution of ABCB1/ABCG2 Substrates to the Human Retina and the
    El Biali M; Karch R; Philippe C; Haslacher H; Tournier N; Hacker M; Zeitlinger M; Schmidl D; Langer O; Bauer M
    Front Pharmacol; 2021; 12():698966. PubMed ID: 34220523
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of single nucleotide polymorphisms of ABCB1, OPRM1 and COMT with pain perception in cancer patients.
    Wang XS; Song HB; Chen S; Zhang W; Liu JQ; Huang C; Wang HR; Chen Y; Chu Q
    J Huazhong Univ Sci Technolog Med Sci; 2015 Oct; 35(5):752-758. PubMed ID: 26489634
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Associations of ABCB1, ABCC2, and ABCG2 polymorphisms with irinotecan-pharmacokinetics and clinical outcome in patients with advanced non-small cell lung cancer.
    Han JY; Lim HS; Yoo YK; Shin ES; Park YH; Lee SY; Lee JE; Lee DH; Kim HT; Lee JS
    Cancer; 2007 Jul; 110(1):138-47. PubMed ID: 17534875
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Correlation between clinical response to sorafenib in hepatocellular carcinoma treatment and polymorphisms of P-glycoprotein (ABCB1) and of breast cancer resistance protein (ABCG2): monocentric study.
    Tandia M; Mhiri A; Paule B; Saffroy R; Cailliez V; Noé G; Farinotti R; Bonhomme-Faivre L
    Cancer Chemother Pharmacol; 2017 Apr; 79(4):759-766. PubMed ID: 28289864
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical utility of ABCB1 and ABCG2 genotyping for assessing the clinical and pathological response to FAC therapy in Mexican breast cancer patients.
    Turiján-Espinoza E; Ruíz-Rodríguez VM; Uresti-Rivera EE; Martínez-Leija E; Zermeño-Nava JJ; Guel-Pañola A; Romano-Moreno S; Vargas-Morales JM; Portales-Pérez DP
    Cancer Chemother Pharmacol; 2021 Jun; 87(6):843-853. PubMed ID: 33740100
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ATP-binding cassette transporter ABCG2 (BCRP) and ABCB1 (MDR1) variants are not associated with disease susceptibility, disease phenotype response to medical therapy or need for surgeryin Hungarian patients with inflammatory bowel diseases.
    Fischer S; Lakatos PL; ; Lakatos L; Kovacs A; Molnar T; Altorjay I; Papp M; Szilvasi A; Tulassay Z; Osztovits J; Papp J; Demeter P; Schwab R; Tordai A; Andrikovics H
    Scand J Gastroenterol; 2007 Jun; 42(6):726-33. PubMed ID: 17505995
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of ABCB1 genetic polymorphisms with susceptibility to colorectal cancer and therapeutic prognosis.
    Wu H; Kang H; Liu Y; Xiao Q; Zhang Y; Sun M; Liu D; Wang Z; Zhao H; Yao W; Jia T; Wang E; Zheng Z; Wei M
    Pharmacogenomics; 2013 Jun; 14(8):897-911. PubMed ID: 23746184
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of ABCB1 Gene (C3435T/A2677G) Polymorphic Sequence Variations on the Outcome of Patients with Chronic Myeloid Leukemia and Acute Lymphoblastic Leukemia in Kashmiri Population: A Case-Control Study.
    Baba SM; Pandith AA; Shah ZA; Geelani SA; Mir MM; Bhat JR; Bhat GM
    Indian J Hematol Blood Transfus; 2021 Jan; 37(1):21-29. PubMed ID: 33707832
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.